Direkt zum Inhalt
Merck
  • Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.

Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.

American journal of hematology (2014-10-11)
Meng Lv, Xiao-Su Zhao, Yue Hu, Ying-Jun Chang, Xiang-Yu Zhao, Yuan Kong, Xiao-Hui Zhang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang
ZUSAMMENFASSUNG

We investigated the effects of granulocyte colony-stimulating factor (G-CSF) on monocytic (M), promyelocytic (P), and granulocytic (G) myeloid-derived suppressor cells (MDSCs) both in bone marrow and peripheral blood of 20 healthy donors and the association of MDSCs subgroups with acute and chronic graft-versus-host disease (aGvHD/cGvHD) in 62 patients who underwent haplo-identical allogeneic hematopoietic stem cell transplantation (allo-HSCT). Patients who received a higher absolute counts of M-MDSCs or P-MDSCs exhibited lower incidence of grade II-IV aGvHD (P = 0.001; P = 0.031) and extensive cGvHD (P = 0.011; P = 0.021). In the multivariate analysis, absolute counts of MDSCs in allografts emerged as independent factors that reduced the occurrence of grade II-IV aGvHD (M-MDSCs: HR = 0.087, 95% CI = 0.020-0.381, P = 0.001; P-MDSCs: HR = 0.357, 95% CI = 0.139-0.922, P = 0.033) and extensive cGvHD (M-MDSCs: HR = 0.196, 95% CI = 0.043-0.894, P = 0.035; P-MDSCs: HR = 0.257, 95% CI = 0.070-0.942, P = 0.04). Delayed M-MDSC reconstitution was associated with aGvHD onset. The 3-year cumulative incidence of transplant related mortality and relapse, 3-year probability of disease-free survival, and overall survival did not differ significantly between these subgroups. Our results suggested that G-CSF-induced immune tolerance may be mediated by M/P-MDSCs in allo-HSCT.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Aphidicolin, ≥98% (HPLC), powder
Sigma-Aldrich
Methotrexat, meets USP testing specifications
SAFC
Methotrexat
Supelco
Methotrexat, Pharmaceutical Secondary Standard; Certified Reference Material
Methotrexat, European Pharmacopoeia (EP) Reference Standard
Supelco
Aphidicolin, analytical standard
Methotrexat für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Methotrexat für die Systemeignung, European Pharmacopoeia (EP) Reference Standard